Synapse - Works

Results (13087)

Closing the gap: Implementation of a novel interactive virtual tumor board to improve expert knowledge sharing in malignant hematology

Meeting Abstract

Ciuro, J.; Henry, E.; Housri, N.; Banerjee, R.; Brem, E. A.; Brooks, T.; Derman, B. A.; Hill, B. T.; Hofmeister, C. C.; Lunning, M. A.; more...
Blood (2022)

Fulltext@MSK | Save

Outcome in multiple myeloma patients treated in the era of modern therapies who were admitted to intensive care: A retrospective analysis from a teaching hospital between 2014 and 2019

Meeting Abstract

Gross, Z.; Idlhaj, M.; Karlin, L.; Friggeri, A.; Lazareth, A.; Golfier, C.; Lequeu, H.; Sauvy, F. B.; Sesques, P.; Safar, V.; more...
Blood (2022)

Fulltext@MSK | Save

Healthcare utilization among patients with advanced systemic light chain amyloidosis

Meeting Abstract

Gertz, M. A.; Abonour, R.; Gibbs, S. N.; Finkel, M.; Landau, H.; Lentzsch, S.; Lin, G.; Mahindra, A.; Quock, T. P.; Rosenbaum, C. A.; more...
Blood (2022)

Fulltext@MSK | Save

Microbial changes in response to a plant-based diet and/or supplements in SMM patients: A national multi-arm randomized prospective telehealth study via HealthTree: The nutrition prevention (NUTRIVENTION-2) study

Meeting Abstract

Castro, F.; Sweeney, N. W.; Derkach, A.; Traore, K.; Anuraj, A.; Guttentag, L.; Blaslov, J.; Sahagun, A.; Hydren, J.; Chmielewski, C.; more...
Blood (2022)

Fulltext@MSK | Save

Low intake of fruits and vegetables and high intake of processed meats and juices are associated with risk of MGUS in the national health and nutrition examination survey (NHANES) database

Meeting Abstract

Joseph, J. M.; Tang, L.; Hillengass, J.; Moysich, K.; Landgren, O.; Usmani, S.; Lesokhin, A. M.; McCann, S. E.; Shah, U. A.
Blood (2022)

Fulltext@MSK | Save

BRUIN CLL-314: A phase III open-label, randomized study of pirtobrutinib (LOXO-305) versus ibrutinib in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma

Meeting Abstract

Woyach, J. A.; Wierda, W. G.; Coombs, C. C.; Lewis, K. L.; Gribben, J. G.; Escalon, M. P.; Ceccarelli, M.; Wu, X.; Mato, A. R.
Blood (2022)

Fulltext@MSK | Save

Severe persistent cytopenias following CAR T-cell therapy in patients with large B-cell lymphoma

Meeting Abstract

De Lapuerta, M. C.; Shouval, R.; Tomas, A. A.; Flynn, J. R.; Devlin, S. M.; Batlevi, C. L.; Fein, J. A.; Giralt, S. A.; Lin, R. J.; Nath, K.; more...
Blood (2022)

Fulltext@MSK | Save

Trial in progress: A first-in-human phase 1/2 study of hematopoietic stem cell transplantation (HCT) with VOR33 (CD33-deleted allograft) followed by treatment with gemtuzumab ozogamicin (GO) in patients with CD33+ acute myeloid leukemia (AML) who are at high-risk of post-HCT relapse

Meeting Abstract

Cooper, B. W.; Suh, H. C.; Koura, D.; Koehne, G.; Cho, C.; Bambace, N. M.; Bernard, L.; Shah, N. N.; Walter, R. B.; DiPersio, J. F.; more...
Blood (2022)

Fulltext@MSK | Save

Trial-in-progress: AMC 112: Axicabtagene ciloleucel in relapsed or refractory HIV-associated aggressive B-cell non-Hodgkin lymphoma (NCT05077527)

Meeting Abstract

Epstein-Peterson, Z. D.; Lee, J. Y.; Barta, S. K.; Palomba, M. L.; Noy, A.
Blood (2022)

Fulltext@MSK | Save

Vitalize trial: A phase 2b, open-label, multicenter, randomized parallel-group, two-stage, study of the novel immunotherapeutic, maveropepimut-S, and pembrolizumab with and without intermittent low-dose cyclophosphamide, in subjects with relapsed/refractory diffuse large B-cell lymphoma

Meeting Abstract

Matasar, M. J.; Lee, E.; Leitch, S.; Solh, M.; Teti, J.; Mody, K.; Fiset, S.; Graff, J.
Blood (2022)

Fulltext@MSK | Save